These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 306284)

  • 1. Serum distribution of citrovorum factor and 5-methyltetrahydrofolate following oral and im administration of calcium leucovorin in normal adults.
    Mehta BM; Gisolfi AL; Hutchison DJ; Nirenberg A; Kellick MG; Rosen G
    Cancer Treat Rep; 1978 Mar; 62(3):345-50. PubMed ID: 306284
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacokinetics of leucovorin calcium after intravenous, intramuscular, and oral administration.
    McGuire BW; Sia LL; Leese PT; Gutierrez ML; Stokstad EL
    Clin Pharm; 1988 Jan; 7(1):52-8. PubMed ID: 3257913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Plasma kinetic study following oral administration of leucovorin tablets in patients with gastric cancer--influence of subtotal gastrectomy].
    Nashimoto A; Sasaki J; Akai S; Sato T; Inada S
    Gan To Kagaku Ryoho; 1989 Dec; 16(12):3747-54. PubMed ID: 2596859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between dose rate of [6RS]Leucovorin administration, plasma concentrations of reduced folates, and pools of 5,10-methylenetetrahydrofolates and tetrahydrofolates in human colon adenocarcinoma xenografts.
    Houghton JA; Williams LG; de Graaf SS; Cheshire PJ; Rodman JH; Maneval DC; Wainer IW; Jadaud P; Houghton PJ
    Cancer Res; 1990 Jun; 50(12):3493-502. PubMed ID: 2140289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of rac-leucovorin vs [S]-leucovorin in patients with advanced gastrointestinal cancer.
    Mader RM; Steger GG; Rizovski B; Sieder AE; Locker G; Gnant MF; Jakesz R; Rainer H
    Br J Clin Pharmacol; 1994 Mar; 37(3):243-8. PubMed ID: 8198932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioequivalence of two leucovorin calcium tablet formulations.
    De Vito JM; McGuire BW; De Lap RJ; Weiss AI
    DICP; 1989 Feb; 23(2):153-4. PubMed ID: 2786292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum and cerebrospinal fluid distribution of 5-methyltetrahydrofolate after intravenous calcium leucovorin and intra-Ommaya methotrexate administration in patients with meningeal carcinomatosis.
    Mehta BM; Glass JP; Shapiro WR
    Cancer Res; 1983 Jan; 43(1):435-8. PubMed ID: 6600162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absorption kinetics of orally administered leucovorin calcium.
    McGuire BW; Sia LL; Haynes JD; Kisicki JC; Gutierrez ML; Stokstad EL
    NCI Monogr; 1987; (5):47-56. PubMed ID: 3501546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of leucovorin rescue using a new methotrexate-independent biochemical assay for leucovorin and N5-methyltetrahydrofolate.
    Hamel E; Johnson G; Glaubiger D
    Cancer Treat Rep; 1981; 65(7-8):545-53. PubMed ID: 7018678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of leucovorin metabolites in human plasma as a function of dose administered orally and intravenously.
    Priest DG; Schmitz JC; Bunni MA; Stuart RK
    J Natl Cancer Inst; 1991 Dec; 83(24):1806-12. PubMed ID: 1744924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of the diastereoisomers of leucovorin after intravenous and oral administration to normal subjects.
    Straw JA; Szapary D; Wynn WT
    Cancer Res; 1984 Jul; 44(7):3114-9. PubMed ID: 6609768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative bioavailability and kinetics of folinic acid in the pharmaceutical formulations of Rescuvolin and Ledervorin in healthy volunteers.
    Guelen PJ; Vree TB; de Vos D; Lamers K
    Biopharm Drug Dispos; 1988; 9(1):31-9. PubMed ID: 3257707
    [No Abstract]   [Full Text] [Related]  

  • 13. Effective absorption and utilization of oral formyltetrahydrofolate in man.
    Nixon PF; Bertino JR
    N Engl J Med; 1972 Jan; 286(4):175-9. PubMed ID: 4536622
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacokinetics of 5-methyltetrahydrofolate.
    Strum WB; Hanstein WG
    Res Commun Chem Pathol Pharmacol; 1978 Jun; 20(3):449-56. PubMed ID: 674825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct resolution of the stereoisomers of leucovorin and 5-methyltetrahydrofolate using a bovine serum albumin high-performance liquid chromatographic chiral stationary phase coupled to an achiral phenyl column.
    Wainer IW; Stiffin RM
    J Chromatogr; 1988 Jan; 424(1):158-62. PubMed ID: 3259244
    [No Abstract]   [Full Text] [Related]  

  • 16. Determination of low levels of the stereoisomers of leucovorin and 5-methyltetrahydrofolate in plasma using a coupled chiral-achiral high-performance liquid chromatographic system with post-chiral column peak compression.
    Lin SL; Jadaud P; Whitfield LR; Wainer IW
    J Chromatogr; 1990 Nov; 532(2):227-36. PubMed ID: 2084121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The metabolism of folinic acid (leucovorin) following oral and parenteral administration.
    Taguchi H
    J Nutr Sci Vitaminol (Tokyo); 1981; 27(4):283-90. PubMed ID: 6977022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioavailability of high-dose oral leucovorin.
    Hines JD; Zakem MH; Adelstein DJ; Giroski P; Blum MR; Rustum YM
    NCI Monogr; 1987; (5):57-60. PubMed ID: 3501547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioavailability of sulfamethoxypyridazine following intramuscular or subcutaneous administration in goats.
    Garg SK; Uppal RP
    Vet Res; 1997; 28(1):101-4. PubMed ID: 9172837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A microbiologic disc assay for 5-methyltetrahydrofolate in the presence of methotrexate.
    Mehta BM; Hutchison DJ
    Cancer Treat Rep; 1977 Dec; 61(9):1657-63. PubMed ID: 413623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.